AzTrials
AzTrials

Speech Sound DisorderNCT03623100

Neural Indices of Intervention Outcomes in Children With Speech Sound Disorders

A study testing Speech Production Treatment. and Speech Production + Speech Perception Treatment. in people with Speech Sound Disorder, run by Idaho State University at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Children with speech sound disorders (SSD) are thought to be unable to detect subtle differences between sounds, though there is little understanding of the underlying perceptual mechanisms implicated in SSD. Read more about this study

Who is it for?
Ages 4 to 6 yearsHealthy volunteers can take part
Conditions the study is for
Speech Sound Disorder
What is being tested?
Speech Production Treatment. and Speech Production + Speech Perception Treatment.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
1 siteUnited States
Study dates
1 Aug 2014to 31 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 6 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Between the ages of 4;0 and 6;0 years
  • English monolingual speakers
  • Typical hearing abilities
  • Typical overall development
  • No apparent organic anomalies of the speech mechanism
  • No global cognitive delays
Show all 12Show fewer
  • No receptive language impairments
  • Speech production abilities below the 10th percentile
  • Exclude a minimum of 4 English consonants from sound repertoire
  • No prior speech and/or language intervention services
  • Prior diagnosis of speech sound disorder (SSD)
  • All speech and language measures in the typical range

Who cannot join

  • Speaking a language other than (or in addition to) English
  • Being above the age of 6 years or under 4 years

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Idaho State University - Meridian

    Meridian, Idaho, 83642-7991

Other trials in United States

About this study

Official title: Identification of Electrophysiological Indices of Speech Sound Perception and Change in Children With Speech Sound Disorders

Children with speech sound disorders (SSD) are thought to be unable to detect subtle differences between sounds, though there is little understanding of the underlying perceptual mechanisms implicated in SSD. The investigators suggest that children with SSD may have difficulty creating phonological representations due to inaccurate perception and representation of speech sounds, which then directly impacts speech production abilities. Children will be randomly assigned to one of two treatment conditions in the present study: 1) Traditional speech treatment alone or 2) Traditional speech treatment in conjunction with speech perceptual training. By identifying an underlying mechanism of the disorder, the clinical approach to the treatment of SSD will be better informed and treatment approaches targeting all deficient areas can be utilized.

Read the detailed description

Five to eight percent of all children in the United States have a speech sound disorder (SSD). Children with SSD have difficulty producing sounds of their target language system. Some of these children also have difficulty perceiving and categorizing speech sounds. It is presently unknown what underlying mechanisms might account for the communication problems children with SSD encounter. One possible explanation is that children with SSD cannot produce speech sounds correctly because they have poorly specified phonological representations, which are the result of inaccurate speech sound perception. Thus, speech sound production errors may stem from imprecise speech perception and its resulting sparse phonological representations.

Most children with SSD make slow and steady gains in speech treatment. This is likely due to the fact that speech treatment typically targets just phonetics (i.e., speech production) and phonology (i.e., speech sound knowledge and use). However, it is possible that the underlying mechanisms of speech sound disorders are not specifically phonological in nature but may in fact be related to more general cognitive and/or linguistic impairments. Thus, children will be randomly assigned to one of two treatment conditions in the present study: 1) Traditional speech treatment alone or 2) Traditional speech treatment in conjunction with speech perceptual training.

One goal of the research program is to identify what components of treatment induce the greatest amount of phonological change in children with SSD. By comparing the treatment components, the investigators will be able to identify what treatment activities induce the greatest phonological change in children. This information should aid in developing more efficient and effective treatment programs for SSD.

A second goal of the research program to use electrophysiological measures (electroencephalogram, EEG; event-related potentials, ERP; frequency following responses, FFR) to examine how phonological representations and their associated auditory neural responses change in conjunction with the two traditional speech treatment approaches. A better understanding of phonological representations and the auditory sensory system in children with SSD will inform how speech evaluations and treatment are best conducted by speech-language pathologists.

Being tested
Speech Production Treatment., Speech Production + Speech Perception Treatment.
Keywords
Children, Phonology, EEG, ERP, ABR, FFR
Medical subject headings
Speech Sound Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Speech Production Treatment.Behavioural

    Speech production treatment will be delivered in two phases: Imitation and Spontaneous Production. Treatment will be provided two times weekly in 1-hour sessions, for up to 19 sessions. Every child's intervention program will target a single phoneme that was excluded from his or her phonemic inventory. Each treatment phoneme will be targeted through the production of five words that will be initially introduced to the child using a storybook reading format. Imitation treatment will continue until a child maintains 75% accurate production of the treated phoneme over two consecutive sessions (i.e. performance-based criterion) or until seven consecutive sessions are completed (i.e. time-based criterion). Spontaneous Production will continue until the child maintains either a performance-based criterion of 90% accurate production of the treated phoneme over 3 consecutive sessions, or a time-based criterion of 12 consecutive sessions.

  • Speech Production + Speech Perception Treatment.Behavioural

    This speech treatment condition will be administered in the same way as the Speech Production treatment. The difference in conditions will be that speech treatment in this condition will last for 50 minutes rather than 60 minutes. The remaining 10 minutes of each session will involve the speech perception training. These speech perception tasks will involve previously recorded word-level productions focusing on the same phoneme that is addressed in speech production treatment in word-initial position. A variety of words produced correctly and incorrectly by adults and children will be presented in pairs and the children will have to determine if the words contain the same word-initial phoneme or two different phonemes.

Study groups in NCT03623100
Study groupRoleWhat they receive
Speech TreatmentExperimentalHalf of the children will be assigned to the traditional speech treatment program which will focus on how to produce sounds in academic vocabulary words.
Receives: Behavioral: Speech Production Treatment.
Speech Treatment & PerceptionExperimentalHalf of the children will be assigned to the traditional speech treatment program and speech perception training program combination. This treatment program will teach children not only how to produce sounds in academic vocabulary words, but to also identify correctly and incorrectly produced sounds in words.
Receives: Behavioral: Speech Production + Speech Perception Treatment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline treated sound production accuracy at four months

    Each treated sound will be point-by-point identified as being correct or incorrect in relation to its target phoneme. From these values, generalization data from each child will be examined from both descriptive and quantitative perspectives. Generalization will be descriptively defined using the learning criterion level of 10% or greater accuracy change in treated phonemes (Gierut \& Morrisette, 2012a). For each child and each condition, generalization will be examined to see if the 10% criterion is met. Quantitatively, the amount of change from pre- to post-intervention in treated phoneme accuracy will be calculated separately for each child.

    Measured: an average of 4 months

Secondary outcomes (6)
  1. Change from baseline Mismatch Negativity (MMN) mean amplitude at four months

    Given that the MMN is typically maximal over fronto-central midline electrode sites (e.g., Fz, FCz, and Cz) (Naatanen, Teder, Alho, \& Lavikainen, 1992), these three electrodes will be selected for the mean MMN amplitude analyses. Each maximal peak latency will be first measured in the grand averaged waveforms using the ERPLAB Toolbox (Luck \& Lopez-Calderon, 2012) across the 100-400 ms time window. Peak latencies elicited by the treated sound syllable and ba stimuli will be averaged across the three electrodes to determine the center latency of each peak. The center latency will be then used to align a 100 ms window (50 ms on either side) to measure the mean amplitudes for all electrodes and stimulus types. It is likely that the MMN mean amplitude window will be approximately 250-350 ms.

    Measured: an average of 4 months

  2. Change from baseline P1/P2 mean amplitude at four months

    As every participant might not demonstrate a clear and measurable MMN peak (Cummings, Madden, \& Hefta, 2017), mean amplitude measurements of the auditory P1/P2 ERP peak in the standard and deviant waveforms will also be taken as an additional measure of neural change occurring in conjunction with speech treatment. Three regions of interest (ROI) have been defined and electrodes for each ROI are defined as follows. Left hemisphere ROI channels are F5, FC5, and C5; midline ROI channels are Fz, FCz, and Cz; right hemisphere ROI channels are F6, FC6, and C6. The P1/P2 mean amplitude will be measured across a 100 ms window (100-200 ms post-syllable onset) for both the treated sound syllable and ba for all nine electrodes. The median P1/P2 amplitude for each subject and each ROI for both the pre-treatment and post-treatment assessments will then be calculated.

    Measured: an average of 4 months

  3. Event-related spectral perturbation (ERSP) channel analyses

    ERSP channel analyses will be completed to examine theta (3-6 Hz) and alpha (8-13 Hz) band activity changes occurring in conjunction with speech treatment for both the treated sound and ba syllables. Data from all children will be included in the channel analyses. A left hemisphere region of interest (ROI) and a right hemisphere ROI have been identified to include channels associated with right and left IFG. The left ROI includes the following channels: F5, FC5, C5, F3, FC3, C3; the right ROI includes: F6, FC6, C6, F4, FC4, C4.

    Measured: an average of 4 months

  4. Change from baseline frequency following responses (FFRs) at four months

    The timing, stability, and magnitude of FFRs elicited by consonants have been linked to children's phonological awareness and literacy skills (White-Schwoch et al., 2015). Thus, FFRs, as well as traditional auditory brainstem response (ABR) peaks, will be measured. For each FFR/ABR peak, grand average latency and amplitude measurements will be completed.

    Measured: an average of 4 months

  5. Event-related spectral perturbation (ERSP) independent component (IC) analyses

    ERSP IC analyses will be completed to examine theta (3-6 Hz) and alpha (8-13 Hz) band activity changes occurring in conjunction with speech treatment for both the treated sound and ba syllables. Completing the IC cluster analyses will involve multiple steps. First, the pre- and post-treatment data for the treated sound and ba syllables will be put into separate studies in EEGLAB to examine neural changes occurring in conjunction with speech treatment. EEG component clusters will be identified for each of studies; not every subject is predicted to contribute data to each cluster. To limit the number of analyses, only clusters that have dipoles associated with the right and left inferior frontal gyrus (IFG) will be included. Moreover, the IC cluster analyses will only include data from subjects who have identifiable clusters present in both pre- and post-treatment assessments.

    Measured: an average of 4 months

  6. Change from baseline Percent Consonants Correct (PCC) at four months

    All consonants will be point-by-point identified as being correct or incorrect in relation to its target phoneme. From these values, generalization data from each child will be examined from both descriptive and quantitative perspectives. Generalization will be descriptively defined using the learning criterion level of 10% or greater accuracy change in PCC scores (Gierut \& Morrisette, 2012a). For each child and each condition, generalization will be examined to see if the 10% criterion is met. Quantitatively, the amount of change from pre- to post-intervention in PCC accuracy will be calculated separately for each child.

    Measured: an average of 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2018
  2. Study start1 Aug 2014
  3. Primary completion31 Jul 2024
  4. Study completion31 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A single-subject staggered multiple baseline design will be used in the speech treatment program. Following procedures for this design, the children with SSD will be randomly assigned to one of two treatment conditions. These groups will be evaluated independently and in combination. Every subject will be evaluated in a baseline period in which no treatment is provided. Every subject will first complete a full baseline assessment. Subsequent baselines will consist only of a shorter baseline probe that specifically targets the phonemes each child did not produce during the initial baseline session. Thus, the first subject in each condition will have 2 baselines and then begin treatment. Each subsequent subject within each condition will have 1 additional baseline before beginning treatment.
Masking
None (open label)
Enrolment
42 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03623100
Sponsor's protocol ID
R15DC013359
Other IDs
7R15DC013359
Status last verified
May 2025
First submitted
23 Jul 2018
Last updated
9 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Speech Production Treatment. and Speech Production + Speech Perception Treatment. in people with Speech Sound Disorder, run by Idaho State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 9 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline treated sound production accuracy at four months (time frame: an average of 4 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in